# Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris

> **NCT01707043** · PHASE4 · COMPLETED · sponsor: **Wake Forest University** · enrollment: 20 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Taclonex

## Key facts

- **NCT ID:** NCT01707043
- **Lead sponsor:** Wake Forest University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01707043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01707043, "Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01707043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*